STOCK TITAN

GigCapital5, Inc. Announces Closing Date for Business Combination With QT Imaging

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
QT Imaging Holdings, Inc. is set to begin trading on Nasdaq under the ticker symbols 'QTI' on March 5, 2024, following a successful business combination with GigCapital5, a SPAC. QT Imaging specializes in innovative body imaging systems using low energy sound, with FDA clearance and growth potential in the healthcare market.
Positive
  • None.
Negative
  • None.

The completion of a business combination between GigCapital5, a SPAC and QT Imaging, a medical device company specializing in innovative imaging systems, marks a significant transition for QT Imaging as it prepares to trade publicly under the ticker 'QTI'. This move is expected to increase the company's visibility and access to capital, which could accelerate its growth trajectory. Financial analysts will closely observe the company's post-listing performance to gauge investor confidence and market reception of its technology and business model.

Furthermore, the transition to a public entity requires QT Imaging to adhere to stricter financial reporting standards, which could impact their operational transparency and investor relations. The market will be keen to assess QT Imaging's financial health through its quarterly and annual reports, which will be critical in understanding the company's ability to capitalize on the growth opportunities it has identified in the patient, medical professional and teaching hospital markets.

QT Imaging's focus on automated breast imaging systems using low energy sound positions it within a niche segment of the medical imaging market. A market research analyst would highlight the potential demand for such technologies, given the increasing emphasis on early detection and non-invasive diagnostic methods in healthcare. The analyst would also consider the competitive landscape, evaluating how QT Imaging's products compare with existing imaging solutions and the company's ability to capture market share.

Additionally, the analyst would examine the broader implications of QT Imaging's technology on healthcare delivery, particularly in terms of cost-effectiveness, accessibility and potential to disrupt traditional imaging practices. The ability to offer safe, affordable and accurate imaging could be a game-changer, particularly in underserved markets where such technology could greatly enhance patient outcomes.

From a medical research perspective, the efficacy and safety of QT Imaging's automated breast imaging system are paramount. The fact that the company has achieved premarket FDA clearance indicates a level of validation that could be compelling to medical professionals and institutions. A medical research analyst would delve into the clinical data and peer-reviewed studies to assess the technology's accuracy, resolution and reliability compared to traditional methods such as mammography.

The analyst would also consider the potential for QT Imaging's system to integrate into existing healthcare workflows and its implications for patient care. The technology's impact on diagnostic confidence, speed and patient experience would be key factors in determining its adoption rate and overall contribution to the field of medical imaging.

QT Imaging Holdings, Inc. Expected to Begin Trading on Nasdaq Under Ticker Symbols “QTI” on March 5, 2024

PALO ALTO, Calif.--(BUSINESS WIRE)-- GigCapital5, Inc. (“GigCapital5”; Nasdaq: GIA), a Private-to-Public Equity (PPE)™ entity also known as special purpose acquisition company (“SPAC”), today announced that the completion of their previously announced business combination (the “Business Combination”) with QT Imaging, Inc. (“QT Imaging”), a technology company engaged in an innovative automated breast imaging system producing high-resolution transmission ultrasound images, will take place on March 4, 2024. The Business Combination was approved at an Annual Meeting of GigCapital5’s stockholders on February 20, 2024. Upon completion of the Business Combination, the combined company will change its name to QT Imaging Holdings, Inc. (“QT Imaging Holdings”). QT Imaging Holdings’ shares of common stock are expected to commence trading on the Nasdaq on March 5, 2024 under the new ticker symbols “QTI”.

QT Imaging is a medical device company engaged in the research, development and commercialization of innovative body imaging systems using low energy sound. Supported by a team with well-established roots in the medical device and healthcare industries, QT Imaging’s technologies leverage unprecedented detection and monitoring capabilities and premarket FDA clearance, and its safe, affordable, and accessible treatments are poised to tackle critical healthcare challenges with accuracy and precision. The Company is well positioned to leverage the significant growth opportunities in the patient, medical professional, and teaching hospital markets.

Dr. John Klock, Chief Executive Officer of QT Imaging, said, “The completion of our business combination with GigCapital5 and emergence as a publicly-traded company is a landmark achievement for QT Imaging, and one that we would not have reached without the hard work and focus of our dedicated employees and the support of our partner, GigCapital5.”

Dr. Raluca Dinu, Founding Managing Partner of GigCapital Global and CEO of GigCapital5, said, “The GigCapital team is very proud to have closed our fifth business combination, GigCapital5 with QT Imaging. We stand committed to our mission to guide brilliant teams like QT Imaging as they navigate the journey of becoming a major public enterprise. We are pleased to continue to actively support QT Imaging's growth as part of its Board of Directors and in any other capacity that may be required, as the company enters its next phase of innovation, commercialization, and growth, and we believe it is very well positioned to address rapidly growing customer demand for solutions that augment medical imaging for critical detection, diagnosis, and treatment of disease.”

Dr. Avi Katz, Founding Managing Partner of GigCapital Global and Executive Chairman of the Board of GigCapital5, said, “We are excited about the partnership with QT Imaging. This combination is yet again a successful demonstration of our Private-to-Public Equity (PPE)™ method and our mission to be involved in enterprises that seek to improve the life quality and equality of our planet inhabitants, where we actively partner with leading innovators and differentiators of privately-held high-tech companies on the next chapter of their journey as a fast-growing public company.”

Advisors

Exit Strategy Partners, LLC introduced the parties and advised QT Imaging, Inc. in the transaction. Brown Rudnick LLP is serving as legal counsel and BPM LLP is serving as auditor to QT Imaging. William Blair is serving as Capital Markets Advisor, DLA Piper LLP (US) is serving as legal counsel, and BPM LLP is serving as auditors to GigCapital5.

About QT Imaging Holdings

QT Imaging is a medical device company founded in 2012 and engaged in the research, development, and commercialization of innovative body imaging systems using low energy sound. QT Imaging believes that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable and accessible and its goal is to improve global health outcomes through the development and commercialization of imaging devices that address critical healthcare challenges with accuracy and precision. For more information, please visit: http://QTimaging.com.

About GigCapital5

GigCapital5, Inc. is a Private-to-Public Equity (PPE)™ company, also known as a blank check company or special purpose acquisition company (SPAC), focusing on the technology, media and telecommunications (TMT) and sustainable industries. It was sponsored by GigAcquisitions5, LLC, which was founded by GigFounders, LLC, each a member entity of GigCapital Global, and formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses.

“Private-to-Public Equity (PPE)” is a trademark of GigFounders, LLC, an affiliate GigCapital5, and are used pursuant to agreement.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including the business combination between GigCapital5 and QT Imaging Holdings and the closing of those transactions, and statements regarding QT Imaging Holdings ’s management team’s expectations, hopes, beliefs, intentions, plans, prospects or strategies regarding the future, including possible business combinations, revenue growth and financial performance, product expansion and services. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on our current expectations and beliefs made by the management of GigCapital5 and QT Imaging in light of their respective experience and their perception of historical trends, current conditions and expected future developments and their potential effects on QT Imaging and GigCapital5 as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting QT Imaging Holdings or GigCapital5 will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including regulatory approvals, the ability of the post-combination company to meet the Nasdaq listing standards, product and service acceptance, and that QT Imaging Holdings will have sufficient capital to operate as anticipated. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Additional factors that could cause actual results to differ are discussed under the heading “Risk Factors” and in other sections of GigCapital5’s filings with the SEC, and in GigCapital5’s current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to GigCapital5 and QT Imaging Holdings as of the date hereof, and GigCapital5 and QT Imaging Holdings assume no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

For GigCapital5:



ICR

Brian Ruby

Brian.ruby@icrinc.com

Source: GigCapital5, Inc.

FAQ

When will QT Imaging Holdings, Inc. start trading on Nasdaq?

QT Imaging Holdings, Inc. is expected to commence trading on the Nasdaq on March 5, 2024.

What is the ticker symbol for QT Imaging Holdings, Inc. on Nasdaq?

The ticker symbol for QT Imaging Holdings, Inc. on Nasdaq will be 'QTI'.

What does QT Imaging specialize in?

QT Imaging specializes in innovative body imaging systems using low energy sound.

What type of clearance does QT Imaging have from the FDA?

QT Imaging has premarket FDA clearance for its technologies.

What markets is QT Imaging well positioned to leverage for growth?

QT Imaging is well positioned to leverage growth opportunities in the patient, medical professional, and teaching hospital markets.

GigCapital5, Inc.

NASDAQ:GIA

GIA Rankings

GIA Latest News

GIA Stock Data

30.56M
1.29M
66.3%
24.19%
0.04%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
United States
Palo Alto